Clinical Trials Directory

Trials / Completed

CompletedNCT03148314

Vaginal Misoprostol In Management Of First Trimester Missed Abortion.

Home-Based Extended Low Dose Buccal Misoprostol Versus Hospital-Based Standard Vaginal Dose In Management Of First Trimester Missed Abortion.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The world health organization defined abortion or miscarriage as : the expulsion or extraction from its mother of a fetus or an embryo weighting 500 grams or less ,or any other wise product of gestation of any weight irrespective of gestational age and weather or not there is evidence of life and weather or not the abortion was spontaneous or induced Miscarriage is the most common complication of pregnancy occurring in 10-20% of clinically recognized pregnancies (Bag. It is estimated that around 40% of early pregnancies result in miscarriage. A large majority of those are lost before the menstrual period is missed. More than 80%of abortions occur in first 12 weeks of pregnancy, and the rate decrease there after For clinical purposes: abortion is subdivided into: threatened abortion, inevitable abortion, incomplete abortion ,missed abortion ,septic abortion ,and recurrent abortion

Conditions

Interventions

TypeNameDescription
DRUGvaginal misoprostol(800µgm.x 2 doses 3 hours).
DRUGbuccal/sublingual misoprostol200 µgm.x4 hrs.x 6 doses

Timeline

Start date
2017-07-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2017-05-11
Last updated
2024-04-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03148314. Inclusion in this directory is not an endorsement.